Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of miRNA in preparation of echinococcosis risk assessment or early screening reagent

A technology for risk assessment and echinococcosis, applied in the field of medicine, achieves the effects of good stability, high sensitivity and specificity, and good diagnostic effect

Pending Publication Date: 2022-08-05
NANJING MEDICAL UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, whether miRNA targeting substances necessary for echinococcosis growth can be used as biomarkers for echinococcosis risk assessment has not been reported so far

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of miRNA in preparation of echinococcosis risk assessment or early screening reagent
  • Application of miRNA in preparation of echinococcosis risk assessment or early screening reagent
  • Application of miRNA in preparation of echinococcosis risk assessment or early screening reagent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0029] The present invention will be described in further detail below in conjunction with the embodiments. If the reagents or equipment used are not marked with the manufacturer, they are regarded as conventional products that can be purchased through the market.

[0030] The inventors collected serum from 8 patients with echinococcosis granulosa etiologically confirmed patients (ie, patients with hydatid disease) from the Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, and 8 healthy controls provided by the echinococcosis laboratory of Ningxia Medical University. serum.

[0031] 1. Experimental method:

[0032]1. Use miRNeasy Serum / Plasma Kit to extract total RNA from serum of hydatid patients and healthy controls. The specific operation is as follows: after centrifuging the serum at 3000g for 5 minutes, add 1ml TRIzol and mix by pipetting. Let stand for 10 minutes, add 200ul of chloroform, invert vigorously and mix for 30 seconds, let...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicines, and particularly relates to application of miRNA in preparation of an echinococcosis risk assessment or early screening reagent. The invention relates to a serum miRNA (micro Ribonucleic Acid) marker related to risk assessment or early screening of echinococcosis. The serum miRNA marker is one or more of hsa-miR-516a-5p, hsa-miR-516b-5p, hsa-miR-518e-5p, hsa-miR-519a-5p, hsa-miR-519b-5p, hsa-miR-522-5p, hsa-miR-523-5p, hsa-miR-6852-5p, hsa-miR-1304-3p, hsa-miR-3138, hsa-miR-431-5p, hsa-miR-324-3p, hsa-miR-526b-5p and hsa-miR-5187 As a novel biomarker, the miRNA disclosed by the invention is good in stability and high in sensitivity and specificity.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the application of a miRNA targeting the synthesis pathway of essential substances for hydatid growth in the preparation of hydatid disease risk assessment or early screening reagents. Background technique [0002] Echinococcus granulosus, or hydatid disease, is an important zoonotic parasitic disease caused by Echinococcus granulosus infection of humans. Echinococcus granulosus infection has no obvious symptoms in the early stage, and patients usually do not go to the hospital for treatment. However, the development of hydatid disease to the chronic stage can manifest as cysts in important organs such as liver and lung, and the mortality rate is as high as 2%-4% (McManus DP, ZhangW, Li J, Bartley PB. Echinococcosis. Lancet. 2003; 3629392:1295 -304; doi:10.1016 / S0140-6736(03)14573-4). If effective treatment measures are not taken in time, the mortality of patients can be sig...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6883C12Q1/6888C12N15/11
CPCC12Q1/6883C12Q1/6888C12Q2600/178Y02A50/30
Inventor 王海苏川戴俊程刘巧玉陈晓军马子健
Owner NANJING MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com